The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Overall survival in a trial of orally administered CCR2 inhibitor CCX872 in locally advanced/metastatic pancreatic cancer: Correlation with blood monocyte counts.
 
David Linehan
No Relationships to Disclose
 
Marcus Smith Noel
Speakers' Bureau - Taiho Pharmaceutical
 
Aram F. Hezel
No Relationships to Disclose
 
Andrea Wang-Gillam
No Relationships to Disclose
 
Ferry Eskens
No Relationships to Disclose
 
Stefan Sleijfer
Consulting or Advisory Role - Philips Research (Inst)
Research Funding - AB Science (Inst); Lilly (Inst); Merck KGaA (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Test on circulating tumor cells in prostate cancer
Travel, Accommodations, Expenses - Amgen
 
Ingrid M.E. Desar
No Relationships to Disclose
 
Frans Erdkamp
No Relationships to Disclose
 
Johanna Wilmink
No Relationships to Disclose
 
Janet Diehl
No Relationships to Disclose
 
Antonia Potarca
Employment - ChemoCentryx
Stock and Other Ownership Interests - ChemoCentryx
 
Niky Zhao
Employment - ChemoCentryx
Stock and Other Ownership Interests - ChemoCentryx
 
Shichang Miao
Employment - ChemoCentryx
Stock and Other Ownership Interests - ChemoCentryx
 
Jun Deng
Employment - ChemoCentryx
Stock and Other Ownership Interests - ChemoCentryx
 
Jan Hillson
Employment - ChemoCentryx
Leadership - ChemoCentryx
 
Pirow Bekker
No Relationships to Disclose
 
Thomas J. Schall
Employment - ChemoCentryx
Leadership - ChemoCentryx
Stock and Other Ownership Interests - ChemoCentryx
 
Rajinder Singh
Employment - ChemoCentryx
Leadership - ChemoCentryx
Stock and Other Ownership Interests - ChemoCentryx
Patents, Royalties, Other Intellectual Property - ChemoCentryx